title: Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon.
abstract: It is now half a century since the start of coronary bypass graft surgery (CABG) with the first percutaneous coronary intervention (PCI) following just over a decade later. The relative merits of PCI vs. CABG for stable coronary artery disease (stable-CAD) have continued to be debated ever since and have been the focus of around 20 randomized trials and numerous registry studies, systematic reviews, and meta-analyses. The aim of this review is to identify areas of agreement, disagreement, and uncertainties in the role of PCI and CABG in patients with stable-CAD.
authors.affiliation: Mayo Clinic College of Medicine and Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
authors.forename: David R
authors.initials: DR
authors.lastname: Holmes
authors.affiliation: Cardiovascular Surgery, Oxford University, John Radcliffe Hospital, UK david.taggart@ouh.nhs.uk.
authors.forename: David P
authors.initials: DP
authors.lastname: Taggart
mesh_terms: D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease; D006801:Humans; D019616:Thoracic Surgical Procedures; D016896:Treatment Outcome
keywords: CABG; Mammary artery; PCI; Stent; Surgery